Bronchial Carcinoid

ByRobert L. Keith, MD, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine
Reviewed/Revised May 2023
View Patient Education

Bronchial carcinoids are rare (1 to 2% of all lung cancers in adults), slow-growing, neuroendocrine tumors arising from bronchial mucosa; they affect patients in their 40s to 60s.

Carcinoid tumors develop from neuroendocrine cells in the gastrointestinal tract (90%), pancreas, pulmonary bronchi, and rarely the genitourinary tract. Although carcinoids are often benign or only locally invasive, those affecting the bronchus are frequently malignant. Some carcinoid tumors are endocrinologically active; the likelihood varies by site of origin and is highest for tumors originating in the ileum and proximal colon (40 to 50%) and lower with bronchial carcinoids.

Half of patients with bronchial carcinoid are asymptomatic, and half present with symptoms of airway obstruction, including dyspnea, wheezing, and cough, which often leads to a misdiagnosis of asthma. Recurrent pneumonia, hemoptysis, and chest pain are also common.

Paraneoplastic syndromes, including Cushing syndrome due to ectopic adrenocorticotropic hormone (ACTH), acromegaly due to ectopic growth hormone–releasing factor, and gastrinoma (Zollinger-Ellison syndrome) due to ectopic gastrin production, are more common than carcinoid syndrome, which occurs in < 3% of patients with the tumor.

Carcinoid syndrome symptoms include

  • Flushing

  • Diarrhea

  • Bronchospasm

Chronic sequelae of carcinoid syndrome include

  • Telangiectasias

  • Right-sided valvular heart disease

  • Retroperitoneal fibrosis

A left-sided heart murmur (mitral stenosis or regurgitation) due to serotonin-induced valvular damage occurs rarely with bronchial carcinoids (as opposed to the right-sided valvular lesions of gastrointestinal carcinoids).

Diagnosis of Bronchial Carcinoid

  • Bronchoscopic biopsy

Diagnosis of bronchial carcinoid is based on bronchoscopic biopsy, but evaluation often initially involves chest CT, which reveals tumor calcifications in up to one third of patients.

Increased urinary serotonin and 5-hydroxyindoleacetic acid levels support the diagnosis, but these substances are not commonly elevated.

Treatment of Bronchial Carcinoid

  • Surgery

Treatment of bronchial carcinoid is with surgical removal with or without adjuvant chemotherapy and/or radiation therapy.

Prognosis depends on tumor type. Five-year survival for well-differentiated (typical) carcinoids is > 90% in most series, but lower for atypical tumors.

Drugs Mentioned In This Article
quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
Download the free Merck Manual App iOS ANDROID
Download the free Merck Manual App iOS ANDROID
Download the free Merck Manual App iOS ANDROID